Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fructose intolerance could be the culprit in unexplained abdominal pain and gas

21.10.2002


Researchers recommend testing symptomatic patients for the condition



Researchers at the University of Kansas Medical Center (Kansas City) urge physicians to consider adding fructose breath testing to their diagnostic strategy for patients with unexplained abdominal pain, gas, diarrhea, and intestinal rumbling or gurgling. The recent study’s results, presented at the 67th Annual Scientific Meeting of the American College of Gastroenterology, indicate that fructose malabsorption occurs in a significant proportion of healthy adults.

Fructose -- the simple sugar found in honey, many fruits, and some soft drinks -- is one of the principal sweeteners in the Western diet. Not everyone has the ability to absorb fructose properly, however, and now researchers are discovering that it may play an important role in the onset of common gastrointestinal symptoms, such as bloating, cramps, and diarrhea. These symptoms arise when the fructose is allowed to pass through the digestive tract to the colon, where some bacteria can use the sugar as a food source. Unfortunately, in the process, hydrogen gas is liberated.


After the subjects were given 25 grams of fructose, which is about how much is in a 12-ounce can of soda sweetened with high fructose corn syrup, the researchers collected breath samples. The analysis revealed an abnormal level (greater than 20 parts per million) of hydrogen gas in nearly one-half of the subjects. Hydrogen gas would not be present in breath unless fructose was not digested normally. On a subsequent day, the subjects received 50 grams of fructose, and about three-quarters had hydrogen levels greater than 20 parts per million.

"When given levels of fructose commonly consumed in the Western diet, a significant number of

our subjects had both objective and subjective evidence of fructose malabsorption, meaning that the breath analysis showed hydrogen in excess of 20 parts per million and they had symptoms like gas and diarrhea," said Peter Beyer, M.S., R.D., of the Dietetics and Nutrition Department at the University of Kansas Medical Center. "When patients present with such symptoms, doctors should consider adding breath analysis for fructose intolerance to the arsenal of routine diagnostic tests."

Last year, at ACG’s 66th Annual Scientific Meeting, Young K. Choi, M.D. and colleagues from the University of Iowa performed fructose breath tests on 219 patients with unexplained gas, bloating, and pain. The analysis revealed the abnormal presence of hydrogen or methane gas in 78 percent of the patients and gastrointestinal symptoms in 58 percent.

"If a patient is found to be fructose intolerant and symptomatic, the doctor may recommend a low-fructose diet," said Beyer. "But in severe cases, antibiotic therapy may be required to provide relief."

Melissa Emick | EurekAlert!
Further information:
http://www.acg.gi.org/

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>